You are now leaving the Kedrion website. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES

HIGHLIGHTS

News Highlight Thumbnail - Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius

EVENTS

Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius

This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs

read more 

PLASMA & BIOTHERAPIES

IVIg efficacy in chronic inflammatory polyradiculoneuropathy (CIDP)

Continuous support by Kedrion Biopharma to research and partnering patient associations

read more 

PLASMA & BIOTHERAPIES

German donors expand patient access to life-saving, plasma-derived therapies

In Germany KEDPLASMA operates four state-of-the-art plasma collection centers

read more 
  1. Kedrion - Feature thumbnail

    EVENTS - 09-11-2017

    Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius

    This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs

    read more 
  2. PLASMA & BIOTHERAPIES - 17-12-2016

    IVIg efficacy in chronic inflammatory polyradiculoneuropathy (CIDP)

    Continuous support by Kedrion Biopharma to research and partnering patient associations

    read more 
  3. PLASMA & BIOTHERAPIES - 12-12-2016

    German donors expand patient access to life-saving, plasma-derived therapies

    In Germany KEDPLASMA operates four state-of-the-art plasma collection centers

    read more 
  4. CORPORATE - 20-09-2016

    Kedrion took part in the 17th ESID meeting with 44 international guests

    The conference focused on new insights into PIDs’ diagnosis and therapies

    read more 
For more information please contact: pressoffice@kedrion.com